Involvement of glial cells in the development and progression of Parkinson’s disease
In Parkinson’s, there is a loss of nerve cells - known as neurons - in the part of the brain called the substantia nigra. These cells are responsible for producing dopamine, a chemical that passes messages from the brain to other parts of the body, particularly those involved in the co-ordination of movement. The underlying cause of destruction of the dopamine-producing neurons is unknown. Neuronal death is accompanied by inflammation, involving glial cells within the brain. In Parkinson’s, there is an indication that the glial cells do not function normally, but are termed to be activated. This may contribute towards the destruction of dopamine-producing cells and impairment of production of essential growth factors required for dopamine nerve cell survival.
Similar entries
- Modulation of metabotropic glutamate receptors as a novel neuroprotective strategy in Parkinson’s disease: A preliminary investi
- Developing a source of neurons to replace the nerve cells lost in Parkinson’s
- The effect of dopamine replacement therapy on behaviour in people with Parkinson’s disease
- Parkinson's stem cell breakthrough
- New funding at University of Oxford for research into faulty brain signalling in Parkinson's
- Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
- Major new lead for Parkinson's treatment
- Scientists artificially grow brain cells from Parkinson's patients to find treatment
- New funding at Oxford for research into the potential benefits of nicotine
- Neuroprotective effects of superoxide dismutase delivery in a viral vector in experimental Parkinson's disease





